KLK3 and metastatic neoplasm: Prostate-specific antigen (PSA) screening for PCa, although controversial because of the associated false-positive results, overdiagnosis, overtreatment and the related complications,11 remains a practical method of early detection, early treatment and prevention of metastatic disease and complication,12 especially in Africa where there is higher mortality compared with other regions of the world.13